Published on 20.09.23
Strengthening the efficacy of cellular immunotherapy against cancer: exploiting T...
Among the available immunotherapies, CAR-T cell therapy has demonstrated remarkable efficacy against certain blood cancers, albeit only in about half of patients. A major contributing factor to this limitation lies in the premature dysfunction of these artificially engineered immune cells, cultivated in laboratory conditions.